Featured Research

from universities, journals, and other organizations

ADHD drug effective for people with dependency

Date:
October 14, 2013
Source:
Karolinska Institutet
Summary:
People with ADHD and substance dependence rarely respond as they should to ADHD medication. A randomized study from Karolinska Institutet now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses.

People with ADHD and substance dependence rarely respond as they should to ADHD medication. A randomised study from Karolinska Institutet now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses. The results of the study are published in the scientific journal Addiction.

Related Articles


ADHD is much more common in people who use drugs than in the population at large. ADHD can be treated with methylphenidate, a CNS stimulant used for both children and adults. However, no previous studies have been able to show that methylphenidate is effective against ADHD in people with dependence. One possible reason for this lack of potency is that the doses tested were too low to have an effect on people with ADHD and long-standing substance dependence, since such individuals have often developed a tolerance to CNS stimulants.

In this latest study, researchers examined the effect of the medication on prison inmates with ADHD and amphetamine dependency, using doses up to double those administered in previous studies. What they found was that the experimental group had fewer relapses into drug use, displayed fewer ADHD symptoms and adhered to their treatment regimens for longer than the placebo group.

"We've shown for the first time that ADHD in these patients is treatable," says lead-author Dr Maija Konstenius at the Department of Clinical Neuroscience. "Moreover, the treatment led to fewer relapses to drug use, which is a very significant finding since a return to crime is often linked to drug abuse in this group."

The present study was a randomised placebo-controlled clinical trial involving 54 incarcerated men diagnosed with ADHD and with amphetamine dependence. The participants were randomly assigned to either of two groups, one that received methylphenidate (Concerta) and one that received an identical placebo (inactive pill) for a total of 24 weeks. The participants began their treatment two weeks before their release from prison and then continued it during non-custodial care. They also received psychological therapy to help them handle the risk of relapsing into drug use.

The study was conducted in partnership with the Stockholm County Council and the Swedish Prison and Probation Service and was financed by grants from the Swedish Research Council and other bodies. Study leader was Professor Johan Franck, Karolinska Institutet.


Story Source:

The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.


Journal Reference:

  1. Maija Konstenius, Nitya Jayaram-Lindstrφm, Joar Guterstam, Olof Beck, Bjφrn Philips, Johan Franck. Methylphenidate for ADHD and Drug Relapse in Criminal Offenders with Substance Dependence: A 24-week Randomized Placebo-controlled Trial. Addiction, 2013; DOI: 10.1111/add.12369

Cite This Page:

Karolinska Institutet. "ADHD drug effective for people with dependency." ScienceDaily. ScienceDaily, 14 October 2013. <www.sciencedaily.com/releases/2013/10/131014093913.htm>.
Karolinska Institutet. (2013, October 14). ADHD drug effective for people with dependency. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2013/10/131014093913.htm
Karolinska Institutet. "ADHD drug effective for people with dependency." ScienceDaily. www.sciencedaily.com/releases/2013/10/131014093913.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Christmas Kissing Good for Health

Christmas Kissing Good for Health

Reuters - Innovations Video Online (Dec. 22, 2014) — Scientists in Amsterdam say couples transfer tens of millions of microbes when they kiss, encouraging healthy exposure to bacteria. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Brain-Dwelling Tapeworm Reveals Genetic Secrets

Brain-Dwelling Tapeworm Reveals Genetic Secrets

Reuters - Innovations Video Online (Dec. 22, 2014) — Cambridge scientists have unravelled the genetic code of a rare tapeworm that lived inside a patient's brain for at least four year. Researchers hope it will present new opportunities to diagnose and treat this invasive parasite. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) — A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) — Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins